AbCellera Biologics (ABCL) Tax Rate (2021 - 2026)

AbCellera Biologics' Tax Rate history runs 6 years deep, the most recent figure standing at 12.86% for Q1 2026.

• Quarterly Tax Rate fell 103.0% year-over-year to 12.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.34% (down 297.0% YoY) and the FY2025 annual result came in at 17.56%, down 117.0% from the prior year.
• Tax Rate was 12.86% for Q1 2026 at AbCellera Biologics, down from 54.13% in the prior quarter.
• Across five years, Tax Rate topped out at 54.13% in Q4 2025 and bottomed at 1.47% in Q2 2022.
• A 5-year average of 18.74% and a median of 16.94% in 2025 frame the typical range for Tax Rate.
• Peak annual rise in Tax Rate reached 2847 bps in 2022, while the deepest fall reached 2440 bps in 2022.
• AbCellera Biologics' Tax Rate stood at 4.84% in 2022, then slumped by 38 bps to 2.99% in 2023, then soared by 802 bps to 26.95% in 2024, then surged by 101 bps to 54.13% in 2025, then plunged by 76 bps to 12.86% in 2026.
• Business Quant data shows ABCL's Tax Rate at 12.86% in Q1 2026, 54.13% in Q4 2025, and 16.94% in Q3 2025.